Wenzhou Kangning Hospital Past Earnings Performance
Past criteria checks 2/6
Wenzhou Kangning Hospital's earnings have been declining at an average annual rate of -27.1%, while the Healthcare industry saw earnings growing at 5.1% annually. Revenues have been growing at an average rate of 16.6% per year. Wenzhou Kangning Hospital's return on equity is 6.2%, and it has net margins of 5.4%.
Key information
-27.1%
Earnings growth rate
-27.3%
EPS growth rate
| Healthcare Industry Growth | 11.3% |
| Revenue growth rate | 16.6% |
| Return on equity | 6.2% |
| Net Margin | 5.4% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
Estimating The Fair Value Of Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)
Feb 28
Investors Continue Waiting On Sidelines For Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)
Jan 19Wenzhou Kangning Hospital (HKG:2120) Has A Somewhat Strained Balance Sheet
Nov 23Wenzhou Kangning Hospital (HKG:2120) Could Be Struggling To Allocate Capital
Jun 16Returns Are Gaining Momentum At Wenzhou Kangning Hospital (HKG:2120)
Mar 23Is Wenzhou Kangning Hospital (HKG:2120) Using Too Much Debt?
Dec 06Returns On Capital Are Showing Encouraging Signs At Wenzhou Kangning Hospital (HKG:2120)
Aug 11Calculating The Fair Value Of Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)
Jul 09Wenzhou Kangning Hospital (HKG:2120) Is Experiencing Growth In Returns On Capital
May 12Wenzhou Kangning Hospital (HKG:2120) Has A Pretty Healthy Balance Sheet
Apr 10Wenzhou Kangning Hospital Co., Ltd.'s (HKG:2120) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 25Will Wenzhou Kangning Hospital (HKG:2120) Multiply In Value Going Forward?
Jan 17
Should You Use Wenzhou Kangning Hospital's (HKG:2120) Statutory Earnings To Analyse It?
Dec 23If You Had Bought Wenzhou Kangning Hospital's (HKG:2120) Shares Five Years Ago You Would Be Down 42%
Dec 10Can Mixed Fundamentals Have A Negative Impact on Wenzhou Kangning Hospital Co., Ltd. (HKG:2120) Current Share Price Momentum?
Nov 27Revenue & Expenses BreakdownBeta
How Wenzhou Kangning Hospital makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 1,596 | 86 | 237 | 32 |
| 30 Sep 23 | 1,560 | 33 | 235 | 33 |
| 30 Jun 23 | 1,525 | -19 | 233 | 33 |
| 31 Mar 23 | 1,505 | -22 | 228 | 33 |
| 31 Dec 22 | 1,485 | -24 | 224 | 33 |
| 30 Sep 22 | 1,456 | 12 | 213 | 32 |
| 30 Jun 22 | 1,428 | 48 | 203 | 31 |
| 31 Mar 22 | 1,363 | 46 | 192 | 30 |
| 31 Dec 21 | 1,297 | 44 | 182 | 28 |
| 30 Sep 21 | 1,207 | 45 | 155 | 29 |
| 30 Jun 21 | 1,132 | 54 | 139 | 30 |
| 31 Mar 21 | 1,060 | 55 | 136 | 26 |
| 31 Dec 20 | 989 | 56 | 133 | 21 |
| 30 Sep 20 | 968 | 49 | 148 | 14 |
| 30 Jun 20 | 947 | 42 | 162 | 6 |
| 31 Mar 20 | 904 | 49 | 157 | 6 |
| 31 Dec 19 | 861 | 57 | 152 | 6 |
| 30 Sep 19 | 814 | 74 | 139 | 7 |
| 30 Jun 19 | 768 | 91 | 126 | 8 |
| 31 Mar 19 | 757 | 86 | 124 | 7 |
| 31 Dec 18 | 746 | 81 | 122 | 6 |
| 30 Sep 18 | 743 | 73 | 123 | 4 |
| 30 Jun 18 | 740 | 65 | 123 | 2 |
| 31 Mar 18 | 703 | 57 | 115 | 2 |
| 31 Dec 17 | 666 | 49 | 107 | 2 |
| 30 Sep 17 | 588 | 58 | 92 | 1 |
| 30 Jun 17 | 509 | 67 | 77 | 0 |
| 31 Mar 17 | 462 | 68 | 77 | 0 |
| 31 Dec 16 | 415 | 69 | 77 | 0 |
| 30 Sep 16 | 394 | 62 | 79 | 0 |
| 30 Jun 16 | 373 | 55 | 81 | 0 |
| 31 Mar 16 | 358 | 55 | 73 | 0 |
| 31 Dec 15 | 344 | 56 | 64 | 0 |
| 30 Sep 15 | 332 | 56 | 59 | 0 |
| 30 Jun 15 | 319 | 56 | 53 | 0 |
| 31 Mar 15 | 308 | 54 | 50 | 0 |
| 31 Dec 14 | 296 | 51 | 48 | 0 |
| 31 Dec 13 | 226 | 36 | 39 | 0 |
Quality Earnings: 2120 has high quality earnings.
Growing Profit Margin: 2120 became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 2120's earnings have declined by 27.1% per year over the past 5 years.
Accelerating Growth: 2120 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: 2120 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (13.4%).
Return on Equity
High ROE: 2120's Return on Equity (6.2%) is considered low.